| Followers | 200 |
| Posts | 25597 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Tuesday, August 30, 2022 2:18:17 AM
I agree about FDA and Pazdur. But the UK’s approval will also flow through the Access Consortium, which will also be a positive and be more than just the UK. It provides access to markets with 145-150 million people.
Of course US approval will be far more meaningful and positive. But UK approval is not nothing.
“The Access Consortium aims to provide patients with timely access to high quality, safe and effective therapeutic products across the five countries. To accomplish this, the agencies work together using high standards of scientific rigour and integrity to reduce regulatory duplication.
According to the consortium, the MHRA will bring additional resources and expertise to the group and will officially begin collaborating as a full member on the 1 January 2021 with a period of shadowing prior to this date.”
https://www.europeanpharmaceuticalreview.com/news/130292/mhra-joins-international-regulatory-consortium/
It’s kind of like Project Orbis and there is some overlap but more countries too. Also former commonwealth countries tend to approve drugs approved in the UK.
Of course US approval will be far more meaningful and positive. But UK approval is not nothing.
“The Access Consortium aims to provide patients with timely access to high quality, safe and effective therapeutic products across the five countries. To accomplish this, the agencies work together using high standards of scientific rigour and integrity to reduce regulatory duplication.
According to the consortium, the MHRA will bring additional resources and expertise to the group and will officially begin collaborating as a full member on the 1 January 2021 with a period of shadowing prior to this date.”
https://www.europeanpharmaceuticalreview.com/news/130292/mhra-joins-international-regulatory-consortium/
It’s kind of like Project Orbis and there is some overlap but more countries too. Also former commonwealth countries tend to approve drugs approved in the UK.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
